Deutsche Bank started coverage on shares of Select Medical (NYSE:SEM) in a research report sent to investors on Monday morning, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $22.00 price objective on the health services provider’s stock.
Other equities analysts also recently issued research reports about the stock. ValuEngine raised shares of Select Medical from a sell rating to a hold rating in a research note on Wednesday, May 22nd. TheStreet raised shares of Select Medical from a c+ rating to a b- rating in a research note on Thursday, June 27th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of Hold and a consensus price target of $18.00.
Shares of SEM stock opened at $16.89 on Monday. The company’s fifty day simple moving average is $16.28 and its 200-day simple moving average is $15.19. Select Medical has a 52 week low of $12.96 and a 52 week high of $20.24. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 4.18. The company has a market cap of $2.30 billion, a PE ratio of 16.40, a P/E/G ratio of 1.13 and a beta of 1.33.
In related news, SVP Scott A. Romberger sold 9,344 shares of Select Medical stock in a transaction on Monday, September 9th. The shares were sold at an average price of $17.26, for a total transaction of $161,277.44. Following the sale, the senior vice president now owns 146,620 shares of the company’s stock, valued at approximately $2,530,661.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Robert G. Breighner, Jr. sold 3,589 shares of Select Medical stock in a transaction on Monday, August 5th. The stock was sold at an average price of $15.22, for a total transaction of $54,624.58. Following the sale, the vice president now directly owns 33,035 shares in the company, valued at approximately $502,792.70. The disclosure for this sale can be found here. Insiders own 19.50% of the company’s stock.
A number of institutional investors have recently added to or reduced their stakes in SEM. Coastal Investment Advisors Inc. acquired a new position in Select Medical during the 2nd quarter worth $39,000. Point72 Hong Kong Ltd acquired a new stake in shares of Select Medical in the second quarter worth $56,000. Royal Bank of Canada lifted its stake in shares of Select Medical by 105.6% in the second quarter. Royal Bank of Canada now owns 3,862 shares of the health services provider’s stock worth $62,000 after buying an additional 1,984 shares during the last quarter. Tower Research Capital LLC TRC acquired a new stake in shares of Select Medical in the second quarter worth $66,000. Finally, Ladenburg Thalmann Financial Services Inc. lifted its stake in shares of Select Medical by 79.7% in the second quarter. Ladenburg Thalmann Financial Services Inc. now owns 5,412 shares of the health services provider’s stock worth $86,000 after buying an additional 2,400 shares during the last quarter. 75.47% of the stock is currently owned by hedge funds and other institutional investors.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Story: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.